PharmaDeals Reports
PharmaDeals' new report on valuation provides an essential grounding in how to use proven and reliable methods for maximising the value of pharmaceutical and biotechnology projects.
Approaches to Valuation of Pharmaceutical Licensing Deals
This guide provides essential insight on the issues of most concern to business development and licensing professionals worldwide. It fully addresses concepts in financial modelling and provides detailed valuation examples.
Building on PharmaDeals' established reputation in the area of deal and alliances, this report:
- Provides a thorough understanding of robust valuation methodologies
- Enables more rigorous economic portfolio analysis
- Assists the formulation of attractive deal structures
- Offers greater transparency in portfolio analysis
- Permits accurate comparison of alternative deals
- Highlights the value creation process
- Minimises risk in future deals
It is an essential reference source for all those aiming to maximise deal values and minimise risk.
Also available in Electronic version (ISBN: 978-0-9568270-5-0). Please contact us for a tailored quote for your organisation.
Also available in Electronic version (ISBN: 978-0-9568270-5-0). Please contact us for a tailored quote for your organisation.
Contact us today
pdenquiries@uk.imshealth.com
pdenquiries@uk.imshealth.com
